Roche buys an informatics provider; Bayer taps Cardinal for manufacturing;

> Roche ($RHHBY) acquired informatics outfit Bina Technologies. Story

> Bayer has reached out to Cardinal Health to manufacture the cancer drug Xofigo in the U.S. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.